1. Home
  2. SQNS vs TLSA Comparison

SQNS vs TLSA Comparison

Compare SQNS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQNS
  • TLSA
  • Stock Information
  • Founded
  • SQNS 2003
  • TLSA 2013
  • Country
  • SQNS France
  • TLSA United Kingdom
  • Employees
  • SQNS N/A
  • TLSA N/A
  • Industry
  • SQNS Semiconductors
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQNS Technology
  • TLSA Health Care
  • Exchange
  • SQNS Nasdaq
  • TLSA Nasdaq
  • Market Cap
  • SQNS 85.7M
  • TLSA 87.8M
  • IPO Year
  • SQNS 2011
  • TLSA 2000
  • Fundamental
  • Price
  • SQNS $2.63
  • TLSA $0.79
  • Analyst Decision
  • SQNS Strong Buy
  • TLSA
  • Analyst Count
  • SQNS 1
  • TLSA 0
  • Target Price
  • SQNS $7.50
  • TLSA N/A
  • AVG Volume (30 Days)
  • SQNS 119.9K
  • TLSA 1.1M
  • Earning Date
  • SQNS 02-11-2025
  • TLSA 02-25-2025
  • Dividend Yield
  • SQNS N/A
  • TLSA N/A
  • EPS Growth
  • SQNS N/A
  • TLSA N/A
  • EPS
  • SQNS 2.00
  • TLSA N/A
  • Revenue
  • SQNS $36,762,000.00
  • TLSA N/A
  • Revenue This Year
  • SQNS $10.14
  • TLSA N/A
  • Revenue Next Year
  • SQNS $8.54
  • TLSA N/A
  • P/E Ratio
  • SQNS $1.25
  • TLSA N/A
  • Revenue Growth
  • SQNS 9.36
  • TLSA N/A
  • 52 Week Low
  • SQNS $0.85
  • TLSA $0.41
  • 52 Week High
  • SQNS $7.30
  • TLSA $1.74
  • Technical
  • Relative Strength Index (RSI)
  • SQNS 37.45
  • TLSA 56.56
  • Support Level
  • SQNS $2.47
  • TLSA $0.65
  • Resistance Level
  • SQNS $3.39
  • TLSA $0.70
  • Average True Range (ATR)
  • SQNS 0.22
  • TLSA 0.05
  • MACD
  • SQNS -0.08
  • TLSA 0.01
  • Stochastic Oscillator
  • SQNS 17.39
  • TLSA 100.00

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: